PREVENTION DE LA COAGULATION INTRAVASCULAIRE DISSEMINEE AU COURS DU PHENOMENE DE SCHWARTZMAN GENERALISE CHEZ LE LAPIN PAR UN SYSTEME ENZYMATIQUE CONSOMMANT L'ADP PLASMATIQUEZAWILSKA K; IZRAEL V; CHELLOUL N et al.1975; ACTUAL. HEMATOL.; FR.; DA. 1975; VOL. 9; PP. 269-286; BIBL. 1 P.Article

Haemolytic-uraemic syndrome associated with sepsis due to Salmonella enteritidisGRZYWACZ, A; PSUJA, P; ZAWILSKA, K et al.Thrombotic and haemorrhagic disorders. 1993, Vol 7, Num 1, pp 23-25, issn 0934-9669Article

Age-related changes in plasma endogenous heparin-like activity in healthy male volunteersLEWANDOWSKI, K; KULINSKA, A; ZOZULINSKA, M et al.Thrombosis research. 1991, Vol 62, Num 1-2, pp 109-114, issn 0049-3848Article

Binding of heparin to human endothelial cell monolayer and extracellular matrix in culturePSUJA, P; DROUET, L; ZAWILSKA, K et al.Thrombosis research. 1987, Vol 47, Num 4, pp 469-478, issn 0049-3848Article

The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbitsZAWILSKA, K; ZOZULINSKA, M; TUROWIECKA, Z et al.Thrombosis research. 1993, Vol 69, Num 3, pp 315-320, issn 0049-3848Article

The influence of physical exercise and intravenous heparin on plasmatic concentration of platelet factor 4 in young survivors of myocardial infarctionZAWILSKA, K; ELIKOWSKI, W; ZOZULINSKA, M et al.Thrombosis research. 1989, Vol 55, Num 1, pp 155-160, issn 0049-3848Article

An alternative method for identifying the factor V gene Leiden mutationLEWANDOWSKI, K; ROZEK, M; ZAWILSKA, K et al.Thrombosis research. 1997, Vol 85, Num 2, pp 105-113, issn 0049-3848Article

On the action of a heparan-like glycosaminoglycan (hemovasal) on the mechanism of haemostasis and fibrinolysisZAWILSKA, K; ELIKOWSKI, W; TUROWIECKA, Z et al.Thrombosis research. 1995, Vol 78, Num 3, pp 211-216, issn 0049-3848Article

Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemiaGRZYWACZ, A; ELIKOWSKI, W; PSUJA, P et al.Blood coagulation & fibrinolysis. 1998, Vol 9, Num 3, pp 245-249, issn 0957-5235Article

Low molecular weight heparin and the heparin mobilisable pool of platelet factor 4 are reduced in young survivors of myocardial infarctionLEWANDOWSKI, K; ELIKOWSKI, W; TUROWIECKA, Z et al.Thrombosis research. 1996, Vol 81, Num 6, pp 615-622, issn 0049-3848Article

Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosisLOPACIUK, S; BIELSKA-FALDA, H; ZAWILSKA, K et al.Thrombosis and haemostasis. 1999, Vol 81, Num 1, pp 26-31, issn 0340-6245Article

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis : a polish multicenter trialLOPACIUK, S; MEISSNER, A. J; FILIPECKI, S et al.Thrombosis and haemostasis. 1992, Vol 68, Num 1, pp 14-18, issn 0340-6245Article

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyHOLOWIECKI, J; GROSICKI, S; ZDZIARSKA, B et al.Leukemia. 2004, Vol 18, Num 5, pp 989-997, issn 0887-6924, 9 p.Article

Antiphospholipid antibodies and disturbances of phospholipid dependent coagulation tests in patients with systemic sclerosis and severe peripheral ischaemiaLEWANDOWSKI, K; TUROWIECKA, Z; PUSZCZEWICZ, J et al.Thrombosis research. 1996, Vol 81, Num 6, pp 693-695, issn 0049-3848Article